Skip to main content
Premium Trial:

Request an Annual Quote

Nucleonics Challenges Benitec Patent Application in Poland

NEW YORK, March 4 (GenomeWeb News) - Nucleonics is challenging a patent held by Benitec in Poland, the company said yesterday.

 

Nucleonics said it filed prior art citations, also called a third party observation, with the Polish Patent Office. This prior art, it believes, invalidates claims in Benitec's patent application No. PL 343 064, "Control of Gene Expression." According to Nucleonics, these claims are ambiguous because they lack novelty or did not involve an inventive step at the time the patent application was filed.

 

The latest filing follows a number of challenges of Benitec patents by Nucleonics in other countries. Last year, Nucleonics requested the reexamination of two Benitec patents in Australia, and of one Benitec patent in the US. In January, Nucleonics also filed a third-party observation challenging Benitec's patent application in Europe.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.